Tech Company Financing Transactions
iOrganBio Funding Round
iOrganBio, based in Chapel Hill, secured $2 million from First Star Ventures, Alix Ventures and Cape Fear Ventures.
Transaction Overview
Company Name
Announced On
10/29/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Chapel Hill, NC Undisclosed
USA
Chapel Hill, NC Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
iOrganBio is transforming human cell production with CellForge, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Delubac
Browse more venture capital transactions:
Prev: 10/29/2025: Druo venture capital transaction
Next: 10/29/2025: StampMyVisa venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs